Seikagaku Corp (4548) Stock Price & News

4548:TYO

Seikagaku Corp

¥728.00

-5.94%

(-46.00) 1D

Jun 1, 3:30:00 PM GMT+9 · JPY

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for 4548...

Open

¥770

High

¥774

Low

¥723

Mkt. cap

41.36B

Avg. vol.

140.54K

Volume

280.60K

Dividend

4.12%

Quarterly dividend

¥7

Ex-dividend date

Mar 30, 2026

P/E ratio

26.98

52-wk high

¥820

52-wk low

¥603

EPS

¥27

Shares outstanding

56.40M

No. of employees

Open

¥770

High

¥774

Low

¥723

Mkt. cap

41.36B

Avg. vol.

140.54K

Volume

280.60K

Dividend

4.12%

Quarterly dividend

¥7

Ex-dividend date

Mar 30, 2026

P/E ratio

26.98

52-wk high

¥820

52-wk low

¥603

EPS

¥27

Shares outstanding

56.40M

No. of employees

Related stocks

4536

Santen Pharmaceutical Co Ltd

¥1,857.00

-3.05%

4568

Daiichi Sankyo Co Ltd

¥2,619.00

-3.02%

4538

Fuso Pharmaceutical Industries Ltd

¥2,012.00

-1.28%

4552

JCR Pharmaceuticals Co Ltd

¥465.00

-6.44%

News stories

From sources across the web

Local 3 News

46 minutes ago

RAW: NYSE: CLOSING BELL (MONDAY)

Seeking Alpha

51 minutes ago

3 things to look out for on Tuesday

Stock Titan

27 minutes ago

Domo (NASDAQ: DOMO) schedules 2026 votes on directors, auditor and executive pay

Investor's Business Daily

5 minutes ago

Dow Jones Futures: Broadcom, Micron, Nvidia, Sandisk, Tesla Are Big Movers; AI Stock Credo Plunges On Earnings

About Seikagaku Corp

CEO-

Employees1.08K

FoundedJun 2, 1947

Headquarters-

SectorPharmaceutical industry

Websiteseikagaku.co.jp

All values in JPY	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	8.73B	9.18B	9.02B	9.71B
Cost of goods sold	5.04B	5.67B	5.00B	4.97B
Cost of revenue	5.04B	5.67B	5.00B	4.97B
Research and development expenses	1.69B	1.34B	1.64B	2.34B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.37B	2.37B	2.46B	2.42B
Operating expense	4.06B	3.70B	4.11B	4.76B
Total operating expenses	9.10B	9.37B	9.10B	9.74B
Operating income	-365.00M	-192.00M	-79.00M	-24.00M
Other non operating income	7.00M	93.00M	21.00M	4.00M
EBT including unusual items	-133.00M	493.00M	1.04B	110.00M
EBT excluding unusual items	-132.00M	30.00M	413.00M	110.00M
Income tax expense	67.00M	64.00M	149.00M	-244.00M
Effective tax rate	-50.38%	12.98%	14.34%	-221.82%
Other operating expenses	-	-	-	-
Net income	-200.00M	429.00M	890.00M	354.00M
Net profit margin	-2.29%	4.67%	9.86%	3.65%
Earnings per share	-	-	-	-
Interest and investment income	259.00M	47.00M	253.00M	52.00M
Interest expense	-1.00M	-1.00M	-6.00M	-1.00M
Net interest expenses	258.00M	46.00M	247.00M	51.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	133.75M	334.00M	419.75M	518.75M
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Research